These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
659 related articles for article (PubMed ID: 17362944)
1. Effects of oral fat and glucose tolerance test on serum lipid profile, apolipoprotein, and CRP concentration, and insulin resistance in patients with polycystic ovary syndrome. Bahceci M; Aydemir M; Tuzcu A Fertil Steril; 2007 Jun; 87(6):1363-8. PubMed ID: 17362944 [TBL] [Abstract][Full Text] [Related]
2. Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome. Shi Y; Guo M; Yan J; Sun W; Zhang X; Geng L; Xu L; Chen Z Neuro Endocrinol Lett; 2007 Dec; 28(6):807-10. PubMed ID: 18063948 [TBL] [Abstract][Full Text] [Related]
3. Increased acylation-stimulating protein, C-reactive protein, and lipid levels in young women with polycystic ovary syndrome. Wu Y; Zhang J; Wen Y; Wang H; Zhang M; Cianflone K Fertil Steril; 2009 Jan; 91(1):213-9. PubMed ID: 18206145 [TBL] [Abstract][Full Text] [Related]
4. Abnormal response of insulin to glucose loading and assessment of insulin resistance in non-obese patients with polycystic ovary syndrome. Takeuchi T; Tsutsumi O; Taketani Y Gynecol Endocrinol; 2008 Jul; 24(7):385-91. PubMed ID: 18645711 [TBL] [Abstract][Full Text] [Related]
5. Insulin response to oral glucose in healthy, lean young women and patients with polycystic ovary syndrome. Kulshreshtha B; Ganie MA; Praveen EP; Gupta N; Lal Khurana M; Seith A; Dwivedi SN; Kumar G; Ammini AC Gynecol Endocrinol; 2008 Nov; 24(11):637-43. PubMed ID: 19031221 [TBL] [Abstract][Full Text] [Related]
6. Failure of the homeostatic model assessment calculation score for detecting metabolic deterioration in young patients with polycystic ovary syndrome. Fulghesu AM; Angioni S; Portoghese E; Milano F; Batetta B; Paoletti AM; Melis GB Fertil Steril; 2006 Aug; 86(2):398-404. PubMed ID: 16769061 [TBL] [Abstract][Full Text] [Related]
7. ACTH stimulation test in lean polycystic ovary syndrome patients with insulin resistance. Uncu G; Ozyurek SE; Uncu Y Fertil Steril; 2007 Sep; 88(3):670-4. PubMed ID: 17451692 [TBL] [Abstract][Full Text] [Related]
8. High sensitive serum C-reactive protein and its relationship with other cardiovascular risk factors in normoinsulinemic polycystic ovary patients without metabolic syndrome. Verit FF Arch Gynecol Obstet; 2010 Jun; 281(6):1009-14. PubMed ID: 19771438 [TBL] [Abstract][Full Text] [Related]
9. Effect of rosiglitazone on insulin resistance, growth factors, and reproductive disturbances in women with polycystic ovary syndrome. Belli SH; Graffigna MN; Oneto A; Otero P; Schurman L; Levalle OA Fertil Steril; 2004 Mar; 81(3):624-9. PubMed ID: 15037412 [TBL] [Abstract][Full Text] [Related]
10. Use of fasting blood to assess the prevalence of insulin resistance in women with polycystic ovary syndrome. Carmina E; Lobo RA Fertil Steril; 2004 Sep; 82(3):661-5. PubMed ID: 15374711 [TBL] [Abstract][Full Text] [Related]
11. Can serum apolipoprotein C-I demonstrate metabolic abnormality early in women with polycystic ovary syndrome? Huang S; Qiao J; Li R; Wang L; Li M Fertil Steril; 2010 Jun; 94(1):205-10. PubMed ID: 19368908 [TBL] [Abstract][Full Text] [Related]
12. Adiponectin levels in women with polycystic ovary syndrome and severe insulin resistance. Sepilian V; Nagamani M J Soc Gynecol Investig; 2005 Feb; 12(2):129-34. PubMed ID: 15695109 [TBL] [Abstract][Full Text] [Related]
13. Serum resistin and adiponectin levels in young non-obese women with polycystic ovary syndrome. Arikan S; Bahceci M; Tuzcu A; Kale E; Gökalp D Gynecol Endocrinol; 2010 Mar; 26(3):161-6. PubMed ID: 20148738 [TBL] [Abstract][Full Text] [Related]
14. [Exploration of the classification of polycystic ovarian syndrome]. Lin JF; Li X; Zhu MW Zhonghua Fu Chan Ke Za Zhi; 2006 Oct; 41(10):684-8. PubMed ID: 17199924 [TBL] [Abstract][Full Text] [Related]
15. Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome. Yilmaz M; Biri A; Bukan N; Karakoç A; Sancak B; Törüner F; Paşaoğlu H Gynecol Endocrinol; 2005 May; 20(5):258-63. PubMed ID: 16019370 [TBL] [Abstract][Full Text] [Related]
16. The effects of rosiglitazone and metformin on oxidative stress and homocysteine levels in lean patients with polycystic ovary syndrome. Yilmaz M; Bukan N; Ayvaz G; Karakoç A; Törüner F; Cakir N; Arslan M Hum Reprod; 2005 Dec; 20(12):3333-40. PubMed ID: 16123091 [TBL] [Abstract][Full Text] [Related]
17. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS). Ganie MA; Hassan S; Nisar S; Shamas N; Rashid A; Ahmed I; Douhat S; Mudassar S; Jan VM; Rashid F Gynecol Endocrinol; 2014 Nov; 30(11):781-4. PubMed ID: 25137507 [TBL] [Abstract][Full Text] [Related]
18. Glucose intolerance, insulin resistance and cardiovascular risk factors in first degree relatives of women with polycystic ovary syndrome. Yilmaz M; Bukan N; Ersoy R; Karakoç A; Yetkin I; Ayvaz G; Cakir N; Arslan M Hum Reprod; 2005 Sep; 20(9):2414-20. PubMed ID: 15890734 [TBL] [Abstract][Full Text] [Related]
19. Basal and postprandial plasma levels of PYY, ghrelin, cholecystokinin, gastrin and insulin in women with moderate and morbid obesity and metabolic syndrome. Zwirska-Korczala K; Konturek SJ; Sodowski M; Wylezol M; Kuka D; Sowa P; Adamczyk-Sowa M; Kukla M; Berdowska A; Rehfeld JF; Bielanski W; Brzozowski T J Physiol Pharmacol; 2007 Mar; 58 Suppl 1():13-35. PubMed ID: 17443025 [TBL] [Abstract][Full Text] [Related]
20. Plasma adiponectin and insulin resistance in women with polycystic ovary syndrome. Ardawi MS; Rouzi AA Fertil Steril; 2005 Jun; 83(6):1708-16. PubMed ID: 15950640 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]